Creating novel treatments for human disease

Harnessing the power of interspecies molecular connections

Intersystems Biology™ focuses on how molecular connections between botanical, bacterial, and human cells — co-evolved over millennia — define health and disease. What if we could harness the full power of this ‘pharmacy within us’ to improve human health?

An unprecedented, high-resolution molecular view into interspecies interactions

The Senda discovery platform provides never-before-seen resolution into interspecies molecular connections, with interactions mapped to exact locations across the human gastrointestinal tract.

The Senda discovery platform is able to identify, quantify, and locate molecular connections with far higher resolution than traditional methods.

New categories of life-changing medicines

With unique insights into the trillions of interspecies molecular connections in the human body, we can create novel treatments for human disease — with applications across a wide variety of therapeutic areas.

Medicines exploiting insights from Intersystems Biology™ will:

  1. Achieve systemic health effects while minimizing drug exposure, by targeting the nonhuman species in our body’s ecosystem.
  2. Deliver compounds in highly precise ways, via selectively activated molecules.
  3. Deploy large biomolecules — such as peptides and nucleic acids — through oral administration.

Founded by Flagship Pioneering

Senda Biosciences was founded by Flagship Pioneering, which conceives, creates, resources, and develops first-in-category life sciences companies to transform human health and sustainability. As a Flagship Pioneering company, we come from a long line of unprecedented multi-product platform companies like Moderna Therapeutics (NASDAQ: MRNA), Rubius Therapeutics (NASDAQ: RUBY), Indigo Agriculture, and Sana Biotechnology.

Join our team

Current Job Openings